1. Home
  2. CORT vs PLNT Comparison

CORT vs PLNT Comparison

Compare CORT & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • PLNT
  • Stock Information
  • Founded
  • CORT 1998
  • PLNT 1992
  • Country
  • CORT United States
  • PLNT United States
  • Employees
  • CORT N/A
  • PLNT N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • PLNT Hotels/Resorts
  • Sector
  • CORT Health Care
  • PLNT Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • PLNT Nasdaq
  • Market Cap
  • CORT 7.5B
  • PLNT 8.1B
  • IPO Year
  • CORT N/A
  • PLNT 2015
  • Fundamental
  • Price
  • CORT $69.14
  • PLNT $111.38
  • Analyst Decision
  • CORT Strong Buy
  • PLNT Strong Buy
  • Analyst Count
  • CORT 4
  • PLNT 15
  • Target Price
  • CORT $142.00
  • PLNT $106.60
  • AVG Volume (30 Days)
  • CORT 840.5K
  • PLNT 1.1M
  • Earning Date
  • CORT 08-05-2025
  • PLNT 08-06-2025
  • Dividend Yield
  • CORT N/A
  • PLNT N/A
  • EPS Growth
  • CORT 8.36
  • PLNT 21.55
  • EPS
  • CORT 1.14
  • PLNT 2.11
  • Revenue
  • CORT $685,446,000.00
  • PLNT $1,129,218,000.00
  • Revenue This Year
  • CORT $35.85
  • PLNT $20.70
  • Revenue Next Year
  • CORT $35.22
  • PLNT $10.29
  • P/E Ratio
  • CORT $59.71
  • PLNT $52.28
  • Revenue Growth
  • CORT 30.93
  • PLNT 10.26
  • 52 Week Low
  • CORT $32.33
  • PLNT $68.75
  • 52 Week High
  • CORT $117.33
  • PLNT $114.47
  • Technical
  • Relative Strength Index (RSI)
  • CORT 42.54
  • PLNT 55.46
  • Support Level
  • CORT $67.44
  • PLNT $109.82
  • Resistance Level
  • CORT $70.44
  • PLNT $114.47
  • Average True Range (ATR)
  • CORT 2.02
  • PLNT 2.60
  • MACD
  • CORT -0.30
  • PLNT -0.18
  • Stochastic Oscillator
  • CORT 11.99
  • PLNT 56.17

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

Share on Social Networks: